At close: September 26 at 4:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-7,328.8770
-7,300.1060
-6,557.9500
-1,086.2440
-1,078.4320
Financing Cash Flow
11,320.6710
11,724.9240
13,064.1280
898.7480
1,232.0030
End Cash Position
7,895.8270
10,935.3520
6,510.5340
4.3560
191.8520
Interest Paid Supplemental Data
--
16.5050
22.2410
--
--
Issuance of Capital Stock
11,669.0900
12,234.9290
13,645.6430
--
--
Issuance of Debt
--
--
125.0000
1,078.0150
1,232.0030
Repayment of Debt
--
--
-139.6450
--
--
Repurchase of Capital Stock
--
--
-69.9650
--
--
Free Cash Flow
-7,328.8770
-7,300.1060
-6,557.9500
-1,086.2440
-1,078.4320
12/31/2020 - 1/12/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ATNF 180 Life Sciences Corp.
1.7500
-7.41%
NLSP NLS Pharmaceutics AG
0.1250
-5.87%
FRES Fresh2 Group Limited
1.4700
+2.08%
AZTR Azitra, Inc.
0.5562
-0.68%
SXTP 60 Degrees Pharmaceuticals, Inc.
1.2396
-8.18%
APLM Apollomics, Inc.
0.1330
-2.21%
ALLR Allarity Therapeutics, Inc.
2.2300
-2.62%
GNPX Genprex, Inc.
0.3495
-0.23%
ANEB Anebulo Pharmaceuticals, Inc.
1.9600
+5.95%
REVB Revelation Biosciences, Inc.
0.8367
+9.93%